| Year |
Citation |
Score |
| 2019 |
Johnson-Davis KL, Doyle K. Therapeutic Drug Monitoring in Pregnant Patients. Therapeutic Drug Monitoring. PMID 31609886 DOI: 10.1097/Ftd.0000000000000709 |
0.304 |
|
| 2019 |
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, ... ... Johnson-Davis KL, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: Second consensus report. Therapeutic Drug Monitoring. PMID 31045868 DOI: 10.1097/Ftd.0000000000000640 |
0.327 |
|
| 2019 |
Merrigan S, Johnson-Davis KL. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method to Quantify Gabapentin and Pregabalin in Urine. Methods in Molecular Biology (Clifton, N.J.). 1872: 119-127. PMID 30350285 DOI: 10.1007/978-1-4939-8823-5_12 |
0.376 |
|
| 2019 |
Rule GS, Rockwood AL, Johnson-Davis KL. LC-MS/MS Method for the Quantification of the Leflunomide Metabolite, Teriflunomide, in Human Serum/Plasma. Methods in Molecular Biology (Clifton, N.J.). 1872: 75-83. PMID 30350281 DOI: 10.1007/978-1-4939-8823-5_8 |
0.396 |
|
| 2019 |
Calvaresi E, Wyness S, Jackson A, Genzen J, Johnson-Davis K. Assessing Propylene Glycol Interference at Concentrations Relevant to Serum Levels With Electronic Cigarette Use in an Enzymatic Ethylene Glycol Assay American Journal of Clinical Pathology. 152: S26-S27. DOI: 10.1093/Ajcp/Aqz112.051 |
0.305 |
|
| 2017 |
Wu F, Slawson MH, Johnson-Davis KL. Metabolic Patterns of Fentanyl, Meperidine, Methylphenidate, Tapentadol and Tramadol Observed in Urine, Serum or Plasma. Journal of Analytical Toxicology. PMID 28119437 DOI: 10.1093/Jat/Bkx003 |
0.341 |
|
| 2017 |
Johnson-Davis KL. Opiate & Benzodiazepine Confirmations: To Hydrolyze or Not to Hydrolyze is the Question The Journal of Applied Laboratory Medicine: An Aacc Publication. 2: 564-572. DOI: 10.1373/Jalm.2016.022947 |
0.359 |
|
| 2017 |
Merrigan SD, Kish-Trier E, Seegmiller JC, Johnson-Davis KL. LC–MS/MS method for quantitation of mycophenolic acid, mycophenolic acid acyl-glucuronide, and 7-O-mycophenolic acid glucuronide in serum Clinical Mass Spectrometry. 3: 41-48. DOI: 10.1016/J.Clinms.2017.07.001 |
0.355 |
|
| 2016 |
Yang HS, Wu AH, Johnson-Davis KL, Lynch KL. Development and validation of an LC-MS/MS sulfonylurea assay for hypoglycemia cases in the emergency department. Clinica Chimica Acta; International Journal of Clinical Chemistry. 454: 130-134. PMID 26790752 DOI: 10.1016/J.Cca.2016.01.007 |
0.333 |
|
| 2016 |
Rule GS, Rockwood AL, Johnson-Davis KL. Quantitation of Teriflunomide in Human Serum/Plasma Across a 40,000-Fold Concentration Range by LC/MS/MS. Methods in Molecular Biology (Clifton, N.J.). 1383: 195-203. PMID 26660188 DOI: 10.1007/978-1-4939-3252-8_21 |
0.389 |
|
| 2016 |
Slawson MH, Johnson-Davis KL. Quantitation of Ethyl Glucuronide and Ethyl Sulfate in Urine Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 167-75. PMID 26660185 DOI: 10.1007/978-1-4939-3252-8_18 |
0.353 |
|
| 2016 |
Slawson MH, Johnson-Davis KL. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 105-14. PMID 26660179 DOI: 10.1007/978-1-4939-3252-8_12 |
0.381 |
|
| 2016 |
Slawson MH, Johnson-Davis KL. Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 49-57. PMID 26660173 DOI: 10.1007/978-1-4939-3252-8_6 |
0.391 |
|
| 2016 |
Slawson MH, Johnson-Davis KL. Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 11-9. PMID 26660169 DOI: 10.1007/978-1-4939-3252-8_2 |
0.385 |
|
| 2015 |
Johnson-Davis KL, Sadler AJ, Genzen JR. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory. Journal of Analytical Toxicology. PMID 26668238 DOI: 10.1093/Jat/Bkv133 |
0.358 |
|
| 2015 |
Schniedewind B, Niederlechner S, Galinkin JL, Johnson-Davis KL, Christians U, Meyer EJ. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study. Therapeutic Drug Monitoring. 37: 296-303. PMID 25970506 DOI: 10.1097/Ftd.0000000000000191 |
0.312 |
|
| 2015 |
McMillin GA, Marin SJ, Johnson-Davis KL, Lawlor BG, Strathmann FG. A hybrid approach to urine drug testing using high-resolution mass spectrometry and select immunoassays. American Journal of Clinical Pathology. 143: 234-40. PMID 25596249 DOI: 10.1309/Ajcpmjkbc6Vja1Sp |
0.338 |
|
| 2015 |
Rule GS, Rockwood AL, Johnson-Davis KL. LC-MS/MS Method for Determination of Teriflunomide, Over a 40,000-Fold Dynamic Range Using Overlapping Calibrators. Therapeutic Drug Monitoring. 37: 472-8. PMID 25525756 DOI: 10.1097/Ftd.0000000000000166 |
0.374 |
|
| 2015 |
Marin SJ, Sawyer JC, He X, Johnson-Davis KL. Comparison of drug detection by three quadrupole time-of-flight mass spectrometry platforms. Journal of Analytical Toxicology. 39: 89-95. PMID 25505058 DOI: 10.1093/Jat/Bku134 |
0.362 |
|
| 2015 |
Signorelli H, Lehman C, Johnson-Davis KL. 33: NicAlert Performance Compared to Liquid Chromatography-Tandem Mass Spectrometry and Immunoassay American Journal of Clinical Pathology. 143: A017-A017. DOI: 10.1093/Ajcp/143.Suppl1.018 |
0.316 |
|
| 2014 |
Lin CN, Juenke JM, Johnson-Davis KL. Method validation of a tricyclic antidepressant drug panel in urine by UPLC-MS/MS. Annals of Clinical and Laboratory Science. 44: 431-6. PMID 25361928 |
0.3 |
|
| 2014 |
Petrides AK, Moskowitz J, Johnson-Davis KL, Jannetto PJ, Langman LJ, Clarke W, Marzinke MA. The development and validation of a turbulent flow-liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum. Clinical Biochemistry. 47: 73-9. PMID 25087976 DOI: 10.1016/J.Clinbiochem.2014.07.018 |
0.39 |
|
| 2013 |
McMillin GA, Slawson MH, Marin SJ, Johnson-Davis KL. Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management. Journal of Pain & Palliative Care Pharmacotherapy. 27: 322-39. PMID 24147959 DOI: 10.3109/15360288.2013.847889 |
0.327 |
|
| 2013 |
Juenke JM, Brown PI, Urry FM, Johnson-Davis KL, McMillin GA. Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma. Clinica Chimica Acta; International Journal of Clinical Chemistry. 423: 32-4. PMID 23618971 DOI: 10.1016/J.Cca.2013.04.014 |
0.379 |
|
| 2012 |
Johnson-Davis KL, Juenke JM, Davis R, McMillin GA. Quantification of tricyclic antidepressants using UPLC-MS/MS. Methods in Molecular Biology (Clifton, N.J.). 902: 175-84. PMID 22767118 DOI: 10.1007/978-1-61779-934-1_16 |
0.399 |
|
| 2012 |
Johnson-Davis KL, Thompson CD, Clark CJ, McMillin GA, Lehman CM. Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department. Journal of Analytical Toxicology. 36: 345-8. PMID 22582270 DOI: 10.1093/Jat/Bks028 |
0.351 |
|
| 2012 |
McMillin GA, Johnson-Davis K, Dasgupta A. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood. Therapeutic Drug Monitoring. 34: 222-6. PMID 22322402 DOI: 10.1097/Ftd.0B013E318246D515 |
0.36 |
|
| 2012 |
Juenke JM, McGraw JP, McMillin GA, Johnson-Davis KL. Performance characteristics and patient comparison of the ARK Diagnostics levetiracetam immunoassay with an ultra-high performance liquid chromatography with tandem mass spectrometry detection method. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 529-31. PMID 22137980 DOI: 10.1016/J.Cca.2011.11.018 |
0.318 |
|
| 2011 |
Rockwood AL, Johnson-Davis KL. Mass spectrometry for clinical toxicology: therapeutic drug management and trace element analysis. Clinics in Laboratory Medicine. 31: 407-28. PMID 21907106 DOI: 10.1016/J.Cll.2011.07.003 |
0.309 |
|
| 2011 |
Johnson-Davis KL, De S, Jimenez E, McMillin GA, De BK. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method. Therapeutic Drug Monitoring. 33: 453-9. PMID 21743377 DOI: 10.1097/Ftd.0B013E3182263981 |
0.403 |
|
| 2011 |
Juenke JM, Miller KA, Ford MA, McMillin GA, Johnson-Davis KL. A comparison of two FDA approved lamotrigine immunoassays with ultra-high performance liquid chromatography tandem mass spectrometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. 412: 1879-82. PMID 21693111 DOI: 10.1016/J.Cca.2011.06.009 |
0.367 |
|
| 2011 |
Juenke JM, Wienhoff KA, Anderson BL, McMillin GA, Johnson-Davis KL. Performance characteristics of the ARK diagnostics gabapentin immunoassay. Therapeutic Drug Monitoring. 33: 398-401. PMID 21654348 DOI: 10.1097/Ftd.0B013E318220Bb65 |
0.321 |
|
| 2011 |
Juenke JM, Miller KA, McMillin GA, Johnson-Davis KL. An automated method for supporting busulfan therapeutic drug monitoring. Therapeutic Drug Monitoring. 33: 315-20. PMID 21544019 DOI: 10.1097/Ftd.0B013E318214Cd75 |
0.347 |
|
| 2011 |
Juenke JM, Brown PI, Johnson-Davis KL, McMillin GA. Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection. Therapeutic Drug Monitoring. 33: 209-13. PMID 21297550 DOI: 10.1097/Ftd.0B013E31820B1Fce |
0.321 |
|
| 2010 |
Johnson-Davis KL, McMillin GA, Juenke JM, Ford CD, Petersen FB. Which dose of busulfan is best? Clinical Chemistry. 56: 1061-4. PMID 20585045 DOI: 10.1373/Clinchem.2009.134940 |
0.35 |
|
| 2007 |
Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, Wilkins DG. Persistence of tolerance to methamphetamine-induced monoamine deficits. European Journal of Pharmacology. 559: 46-54. PMID 17239369 DOI: 10.1016/J.Ejphar.2006.11.045 |
0.602 |
|
| 2005 |
Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. Bupropion increases striatal vesicular monoamine transport. Neuropharmacology. 49: 820-30. PMID 16005476 DOI: 10.1016/J.Neuropharm.2005.05.004 |
0.582 |
|
| 2005 |
Truong JG, Wilkins DG, Baudys J, Crouch DJ, Johnson-Davis KL, Gibb JW, Hanson GR, Fleckenstein AE. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity. The Journal of Pharmacology and Experimental Therapeutics. 314: 1087-92. PMID 15901804 DOI: 10.1124/Jpet.105.085951 |
0.593 |
|
| 2004 |
Johnson-Davis KL, Truong JG, Fleckenstein AE, Wilkins DG. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 309: 578-86. PMID 14747615 DOI: 10.1124/Jpet.103.062695 |
0.6 |
|
| 2003 |
Johnson-Davis KL, Fleckenstein AE, Wilkins DG. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. European Journal of Pharmacology. 482: 151-4. PMID 14660016 DOI: 10.1016/J.Ejphar.2003.09.063 |
0.611 |
|
| 2003 |
Johnson-Davis KL, Hanson GR, Keefe KA. Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats. Neurotoxicity Research. 5: 273-81. PMID 12835119 DOI: 10.1007/Bf03033385 |
0.353 |
|
| 2002 |
Johnson-Davis KL, Hanson GR, Keefe KA. Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression. Journal of Neurochemistry. 82: 1472-9. PMID 12354295 DOI: 10.1046/J.1471-4159.2002.01095.X |
0.329 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Wong SH, Johnson-Davis KL, Garrison K, Rankin JD, Muhammad CS. Everolimus TDM using Thermo Fisher QMS immunoassay on Indiko, Beckman DxC, AU680, and AU5800 analyzers. Clinical Biochemistry. PMID 27988326 DOI: 10.1016/J.Clinbiochem.2016.12.003 |
0.299 |
|
| 2015 |
Marin SJ, Doyle K, Chang A, Concheiro-Guisan M, Huestis MA, Johnson-Davis KL. One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. Journal of Analytical Toxicology. PMID 26342055 DOI: 10.1093/Jat/Bkv101 |
0.292 |
|
| 2019 |
Snozek CLH, Corey RL, Buras MR, Johnson-Davis KL. False-Positive Serum Cocaine Screening Results in Patients Undergoing Evaluation for Renal Transplant. Journal of Analytical Toxicology. PMID 30929014 DOI: 10.1093/Jat/Bkz019 |
0.288 |
|
| 2015 |
Powers JL, Melis R, Malmberg E, Johnson-Davis K, Buys S, Lyon E, McMillin GA. 31: Impact of Multiple CYP Variants on Tamoxifen Metabolite Concentrations American Journal of Clinical Pathology. 143: A015-A015. DOI: 10.1093/Ajcp/143.Suppl1.016 |
0.284 |
|
| 2016 |
Barakauskas VE, Bradshaw TA, Smith LD, Lehman CM, Johnson-Davis KL. Process Optimization to Improve Immunosuppressant Drug Testing Turnaround Time. American Journal of Clinical Pathology. PMID 27453440 DOI: 10.1093/Ajcp/Aqw087 |
0.282 |
|
| 2020 |
Johnson-Davis KL, Farnsworth C, Law C, Parker R. Method validation for a multi-element panel in serum by inductively coupled plasma mass spectrometry (ICP-MS). Clinical Biochemistry. PMID 32407718 DOI: 10.1016/J.Clinbiochem.2020.05.002 |
0.281 |
|
| 2016 |
Dasgupta A, Davis B, Slawson MH, Johnson-Davis KL. Effect of Carbamazepine 10, 11-Epoxide on Serum Carbamazepine Measurement Using a New CMIA Assay: Comparison of Values Obtained by Using PETINIA, CEDIA and Liquid Chromatography Combined with Tandem Mass Spectrometry. Annals of Clinical and Laboratory Science. 46: 242-6. PMID 27312546 |
0.262 |
|
| 2010 |
Johnson-Davis KL, Thompson CD, Clark CJ, McMillin GA, Lehman CM. High amphetamine/methamphetamine concentrations in urine can cause error codes on the Ortho Vitros® Fusion 5,1 FS automated chemistry analyzer. Journal of Analytical Toxicology. 34: 607-8. PMID 21073817 DOI: 10.1093/Jat/34.9.607 |
0.262 |
|
| 2015 |
Johnson-Davis KL, Juenke JM, Thomas RL, Bradshaw T. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients. Annals of Clinical and Laboratory Science. 45: 27-31. PMID 25696007 |
0.26 |
|
| 2022 |
Lemaitre F, Budde K, Van Gelder T, Bergan S, Lawson R, Noceti O, Venkataramanan R, Elens L, Moes DJAR, Hesselink DA, Pawinski T, Johnson-Davis KL, De Winter BCM, Pattanaik S, Brunet M, et al. Therapeutic drug monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19. Therapeutic Drug Monitoring. PMID 35944126 DOI: 10.1097/FTD.0000000000001014 |
0.253 |
|
| 2019 |
Merrigan SD, Johnson-Davis KL. A 6 Second Analytical Method for Quantitation of Tacrolimus in Whole Blood by Use of Laser Diode Thermal Desorption Tandem Mass Spectrometry. The Journal of Applied Laboratory Medicine. 3: 965-973. PMID 31639688 DOI: 10.1373/jalm.2018.027243 |
0.251 |
|
| 2023 |
Smith K, Johnson-Davis KL, Shahrokh K. A New Broad-Spectrum Drug Screen for 127 Analytes by LC-MS/MS. The Journal of Applied Laboratory Medicine. PMID 36651125 DOI: 10.1093/jalm/jfac105 |
0.251 |
|
| 2018 |
Johnson-Davis KL. Opiate & Benzodiazepine Confirmations: To Hydrolyze or Not to Hydrolyze is the Question. The Journal of Applied Laboratory Medicine. 2: 564-572. PMID 33636888 DOI: 10.1373/jalm.2016.022947 |
0.25 |
|
| 2023 |
Johnson-Davis KL, Ly D. Quantification of Olanzapine by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 2737: 347-357. PMID 38036836 DOI: 10.1007/978-1-0716-3541-4_32 |
0.249 |
|
| 2015 |
Johnson-Davis KL, Slawson MH. Ethyl Glucuronide Positivity Rate in a Pain Management Population. Journal of Analytical Toxicology. 39: 686-90. PMID 26324207 DOI: 10.1093/Jat/Bkv096 |
0.242 |
|
| 2020 |
Kroner GM, Thomas RL, Johnson-Davis KL. Retrospective Analysis of Pediatric and Adult Populations Using an LC-MS/MS Method for Oxcarbazepine/Eslicarbazepine Metabolite. The Journal of Applied Laboratory Medicine. PMID 33164075 DOI: 10.1093/jalm/jfaa179 |
0.238 |
|
| 2023 |
Johnson-Davis KL, Thomas RL. Quantification of Oxcarbazepine Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 2737: 387-395. PMID 38036839 DOI: 10.1007/978-1-0716-3541-4_35 |
0.237 |
|
| 2021 |
Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, et al. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic Drug Monitoring. 43: 150-200. PMID 33711005 DOI: 10.1097/FTD.0000000000000871 |
0.233 |
|
| 2009 |
Johnson-Davis KL, Moore SJ, Owen WE, Cutler JM, Frank EL. A rapid HPLC method used to establish pediatric reference intervals for vitamins A and E. Clinica Chimica Acta; International Journal of Clinical Chemistry. 405: 35-8. PMID 19361489 DOI: 10.1016/J.Cca.2009.03.058 |
0.224 |
|
| 2022 |
Bajaj AO, Ly D, Johnson-Davis KL. Retrospective analysis of metabolite patterns of clobazam and N-desmethylclobazam in human plasma by LC-MS/MS. Journal of Mass Spectrometry and Advances in the Clinical Lab. 24: 100-106. PMID 35602307 DOI: 10.1016/j.jmsacl.2022.04.005 |
0.218 |
|
| 2019 |
Wiencek JR, Gehrie EA, Keiser AM, Szklarski PC, Johnson-Davis KL, Booth GS. Detection of Nicotine and Nicotine Metabolites in Units of Banked Blood. American Journal of Clinical Pathology. PMID 30715103 DOI: 10.1093/Ajcp/Aqy176 |
0.215 |
|
| 2016 |
Dasgupta A, Khalil SA, Johnson-Davis KL. Analytical performance evaluation of a new Cobas tacrolimus assay on Cobas e411 analyzer: Comparison of values obtained by the CMIA tacrolimus assay and a liquid chromatography combined with tandem mass spectrometric method Annals of Clinical and Laboratory Science. 46: 204-208. |
0.212 |
|
| 2021 |
Clarke WA, Salyer B, Hussey C, Gardiner J, Johnson-Davis K, Milone MC. Multi-Site Evaluation of Immunoassays for Antipsychotic Drug Measurement in Clinical Samples. The Journal of Applied Laboratory Medicine. PMID 34329438 DOI: 10.1093/jalm/jfab062 |
0.208 |
|
| 2012 |
Juenke JM, Brown PI, McMillin GA, Johnson-Davis KL. Rapid and Automated Detection of Ethylene Glycol: Suitable for Hospital Laboratories? American Journal of Clinical Pathology. 138: A139-A139. DOI: 10.1093/Ajcp/138.Suppl1.125 |
0.202 |
|
| 2018 |
Smith KA, Merrigan SD, Johnson-Davis KL. Selecting a Structural Analog as an Internal Standard for the Quantification of 6-Methylmercaptopurine by LC-MS/MS The Journal of Applied Laboratory Medicine. 3: 384-396. DOI: 10.1373/JALM.2018.026187 |
0.201 |
|
| 2018 |
Smith KA, Merrigan SD, Johnson-Davis KL. Selecting a Structural Analog as an Internal Standard for the Quantification of 6-Methylmercaptopurine by LC-MS/MS. The Journal of Applied Laboratory Medicine. 3: 384-396. PMID 33636909 DOI: 10.1373/jalm.2018.026187 |
0.197 |
|
| 2013 |
McMillin GA, Johnson-Davis KL. Issues of Interferences in Therapeutic Drug Monitoring Accurate Results in the Clinical Laboratory: a Guide to Error Detection and Correction. 195-211. DOI: 10.1016/B978-0-12-415783-5.00013-X |
0.194 |
|
| 2020 |
Yang YK, Johnson-Davis KL, Kelly BN, McMillin GA. Demand for Interpretation of a Urine Drug Testing Panel Reflects the Changing Landscape of Clinical Needs; Opportunities for the Laboratory to Provide Added Clinical Value. The Journal of Applied Laboratory Medicine. 5: 858-868. PMID 32875314 DOI: 10.1093/jalm/jfaa119 |
0.193 |
|
| 2022 |
Bajaj AO, Kushnir MM, Kish-Trier E, Law RN, Zuromski LM, Molinelli AR, McMillin GA, Johnson-Davis KL. LC-MS/MS Method for Measurement of Thiopurine Nucleotides (TN) in Erythrocytes and Association of TN Concentrations With TPMT Enzyme Activity. Frontiers in Pharmacology. 13: 836812. PMID 35387339 DOI: 10.3389/fphar.2022.836812 |
0.19 |
|
| 2014 |
Linakis MW, Campbell SC, Stockmann C, Johnson-Davis KL, McMillin GA, Sherwin CMT, Spigarelli MG. Regional Differences in Thiopurine Methyltransferase Activity Clinical Pharmacology in Drug Development. 3: 1-59. PMID 27129141 DOI: 10.1002/Cpdd.148 |
0.187 |
|
| 2016 |
Dasgupta A, Khalil SA, Johnson-Davis KL. Analytical Performance Evaluation of a New Cobas Tacrolimus Assay on Cobas e411 Analyzer: Comparison of Values Obtained by the CMIA Tacrolimus Assay and a Liquid Chromatography Combined with Tandem Mass Spectrometric Method. Annals of Clinical and Laboratory Science. 46: 204-8. PMID 27098629 |
0.179 |
|
| 2019 |
Gruzdys V, Merrigan SD, Johnson-Davis KL. Feasibility of Immunosuppressant Drug Monitoring by a Microsampling Device. The Journal of Applied Laboratory Medicine. 4: 241-246. PMID 31639670 DOI: 10.1373/jalm.2018.028126 |
0.179 |
|
| 2022 |
Bajaj AO, Parker R, Farnsworth C, Law C, Johnson-Davis KL. Method validation of multi-element panel in whole blood by inductively coupled plasma mass spectrometry (ICP-MS). Journal of Mass Spectrometry and Advances in the Clinical Lab. 27: 33-39. PMID 36593911 DOI: 10.1016/j.jmsacl.2022.12.005 |
0.176 |
|
| 2016 |
Powers JL, Buys SS, Fletcher D, Melis R, Johnson-Davis K, Lyon E, Malmberg EM, McMillin GA. Multi-gene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19 and ABCB1. Journal of Clinical Pharmacology. PMID 27198207 DOI: 10.1002/jcph.771 |
0.171 |
|
| 2023 |
Pandya V, Wilker C, Johnson-Davis KL. Longitudinal trends in meconium drug detection in 46 US states between the years 2015-2020. Journal of Analytical Toxicology. PMID 37079848 DOI: 10.1093/jat/bkad024 |
0.17 |
|
| 2020 |
McMillin GA, Johnson-Davis KL, Kelly BN, Scott B, Yang YK. Impact of the Opioid Epidemic on Drug Testing. Therapeutic Drug Monitoring. PMID 33230043 DOI: 10.1097/FTD.0000000000000841 |
0.151 |
|
| 2019 |
Wu F, Melis R, McMillin GA, Johnson-Davis KL. Retrospective Data Analysis of the Influence of Age and Sex on TPMT Activity and Its Phenotype-Genotype Correlation. The Journal of Applied Laboratory Medicine. 3: 827-838. PMID 31639757 DOI: 10.1373/jalm.2018.027276 |
0.143 |
|
| 2023 |
Okoye NC, Zuromski LM, Johnson-Davis KL. Trends in Blood Lead Levels Quantified by ICP-MS: A Reference Laboratory Retrospective Study. The Journal of Applied Laboratory Medicine. PMID 37478813 DOI: 10.1093/jalm/jfad051 |
0.131 |
|
| 2020 |
Kroner GM, Johnson-Davis KL, Doyle K, McMillin GA. Cannabinol (CBN) Cross-Reacts with Two Urine Immunoassays Designed to Detect Tetrahydrocannabinol (THC) Metabolite. The Journal of Applied Laboratory Medicine. 5: 569-574. PMID 32445358 DOI: 10.1093/jalm/jfaa020 |
0.098 |
|
| 2022 |
Neuman MG, Seitz HK, Teschke R, Malnick S, Johnson-Davis KL, Cohen LB, German A, Hohmann N, Moreira B, Moussa G, Opris M. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury. Current Issues in Molecular Biology. 44: 1294-1315. PMID 35723310 DOI: 10.3390/cimb44030087 |
0.064 |
|
| 2021 |
Hunsaker JJH, La'ulu SL, LaGrave D, Murphy W, Reichman HA, Snow TM, McMillin GA, Johnson-Davis KL, Genzen JR. Tobacco and Cannabis Use During Pregnancy. American Journal of Clinical Pathology. PMID 34508553 DOI: 10.1093/ajcp/aqab093 |
0.06 |
|
| 2011 |
Johnson-Davis KL, Fernelius C, Eliason NB, Wilson A, Beddhu S, Roberts WL. Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study. Annals of Clinical and Laboratory Science. 41: 331-9. PMID 22166502 |
0.053 |
|
| 2021 |
Okoye NC, Greene DN, Johnson-Davis KL. Is the Confirmatory Test Always Right? Sometimes Immunoassays Know What They Are Talking About. The Journal of Applied Laboratory Medicine. PMID 34568949 DOI: 10.1093/jalm/jfab097 |
0.03 |
|
| 2011 |
McMillin GA, Johnson-Davis KL. In reply Clinical Chemistry. 57: 644-645. DOI: 10.1373/clinchem.2010.160598 |
0.01 |
|
| Hide low-probability matches. |